Page 57 - Pharma

Novartis completes divestment of animal health biz to Eli Lilly

The $ 5.4-bn deal was announced by the company in April 2014

Lupin receives USFDA approval for HIV drug

The US drug regulator has given its nod for Lupin's darunavir ethanolate tablets, which are the generic versions of Janssen's Prezista tablets

Glenmark Pharma plans to out-license molecule for pain management

The molecule, which has market potential worth $1 billion, has successfully completed phase-II trials on 138 patients in Europe and India

Kabra Drugs to expand facility; target exports market

The company is planning to expand its product range and has started production of herbal products

Amgen ties up with Kite Pharma for cancer drug research

The alliance combines Amgen's oncology targets and Kite's leading CAR T cell therapy platform to develop new therapeutic candidates

Apollo Health acquires Nova Specialty Hospital

The deal, which is expected to be in the range of Rs 135-145 crores, fits into the growth strategy of AHLL providing it a larger footprint, including in some markets where it has no presence currently

Jubilant receives USFDA nod for immunosuppressant & migraine drugs

The company has received ANDA approval for mycophenolate mofetil and rizatriptan

SRF acquires DuPont's global pharma grade HFC 134a refrigerant biz

Indian firm will own DuPont's Dymel brand and will also receive the technology and know-how for setting up its own current cGMP facility for manufacturing HFC 134a pharma grade

Bioadhesives address several unmet needs in key industries

A Frost & Sullivan report finds that animal glues, starch- and gum-based bioadhesives have found uses in key sectors, fulfilling the need for biocompatibility, eco-friendliness and adhesion

Lupin receives USFDA approval for antiretroviral drug

The company received approval for lamivudine tablets 150 mg and 300 mg - a generic version of ViiV Healthcare's Epivir

Torrent inks licensing agreement with Reliance Life Sciences for biosimilars

As per the agreement, Reliance Life Sciences will develop and supply these products to Torrent Pharma after obtaining all necessary regulatory approvals

Dr Reddy's completes acquisition of Habitrol from Novartis

Novartis divested Habitrol (a nicotine replacement therapy transdermal patch) brand following the announcement of GSK and Novartis to combine their global consumer healthcare operations

Cipla's South African arm wins Rs 1095 cr aids drug tender

The company will supply anti-retroviral (ARV) drugs for 2015-17 to South African government

Gujarat and Chemicals Ministry to form joint working group

The aim of the group is to fast-track chemical industry projects in the state

Panacea Biotec enters into a pact with US-based Rising Pharmaceuticals

The two companies will collaborate for Panacea Biotec's oral controlled release product, is currently under review by US Food and Drug Administration (FDA)

Cardinal Health to contract manufacture Bayer's Xofigo in US

US-based firm to build exclusive manufacturing facility for Xofigo (radium Ra 223 dichloride) injection, a radioactive therapeutic agent used to treat patients with cancer

Raaj Medisafe resumes production of hygiene products

The company starts manufacturing of disposable sheets, masks, caps and shoe covers targeted at clinics, hospitals, restaurants, hotels, etc

Emami group companies form JV with Germany's Hevert-Arzneimittel

The JV will focus on homeopathy segment, and will market German company's products in India

Anand Nambiar is the new MD of Merck Ltd

This follows the resignation of its present MD, Dr Claus-Dieter Boedecker, from the company

Strides Arcolab receives USFDA approval for vitamin C softgel capsules

The product will be manufactured at the company's oral dosage facility at Bangalore